4//SEC Filing
Costantino John R 4
Accession 0001209191-08-053731
CIK 0001351197other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 3:19 PM ET
Size
12.6 KB
Accession
0001209191-08-053731
Insider Transaction Report
Form 4
Costantino John R
Director
Transactions
- Award
Warrant (Right to Purchase Common Stock)
2008-09-26+89,292→ 89,292 total(indirect: By NGN BioMed Opportunity I, L.P.)Exercise: $0.75From: 2009-03-26Exp: 2014-03-26→ Common Stock (89,292 underlying) - Purchase
Common Stock
2008-09-26$0.81/sh+129,107$104,899→ 522,378 total(indirect: By NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG) - Purchase
Common Stock
2008-09-26$0.81/sh+178,584$145,100→ 722,566 total(indirect: By NGN BioMed Opportunity I, L.P.) - Award
Warrant (Right to Purchase Common Stock)
2008-09-26+64,554→ 64,554 total(indirect: By NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG)Exercise: $0.75From: 2009-03-26Exp: 2014-03-26→ Common Stock (64,554 underlying)
Footnotes (3)
- [F1]Represents total amount of common stock owned directly by NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG.
- [F2]Mr. Costantino is the Managing General Partner of NGN Capital LLC. NGN Capital LLC is the managing limited partner of NGN BioMed Opportunity I, GmbH & Co. Beteiligungs KG and the sole general partner of NGN BioMed I, GP, L.P, the sole general partner of NGN BioMed Opportunity I, L.P. Mr. Costantino disclaims beneficial ownership of the securities held directly by NGN BioMed Opportunity I, GmbH & Co. Beteiligungs KG, NGN BioMed Opportunity I, L.P. and NGN Capital LLC except to the extent of any indirect pecuniary interest in his distributive share therein.
- [F3]Represents total amount of common stock owned directly by NGN BioMed Opportunity I, L.P.
Documents
Issuer
ARTES MEDICAL INC
CIK 0001351197
Entity typeother
Related Parties
1- filerCIK 0001383128
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 3:19 PM ET
- Size
- 12.6 KB